Database

MYELOMAX

Solution provided
Technology
Supplier identity
General description

Our mission is to assist our clients in the evaluation of drug efficiency, mechanism, identification of biomarkers in Multiple Myeloma, a cancer that allows introduction of new types of therapeutic molecules for treatment of cancers (proteasome inhibitors, immunomodulators)

Type of Supplier
Service Provider - CMO / CRO
Region
Regions of Pays de la Loire, Centre and Poitou-Charentes, FR
Regional access broker
  • Grégory Bauer, Atlanpole Biotherapies
Activity description
The 3 top equipments available

Over past decades, Myelomax founders have developed and characterized a large collection of Human Multiple Myeloma Cell Lines covering Multiple Myeloma diversity making the collection a unique tool to study Multiple Myeloma.

Training and Staff possibilities
No
Contact information
Name
MENORET
Surname
Emmanuelle
Function
CEO
Phone number
+33 (0)2 28 08 00 40
Address
IRT 1 - 8 quai Montcousu
BP 70721
44007  Nantes cedex 1
France